Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

Sarah Longwell, Publisher for The Bulwark and Robert Armstrong, US Financial Commentator for The Financial Times join Nicolle Wallace on Deadline White House to discuss who appear to be bearing the ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI has skyrocketed 21% in the last three days, fueled by news of a $200 million partnership with AstraZeneca and ...

CHICAGO, April 25, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to ...

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and comprehensive generative artificial intelligence model for oncology.

Tempus stands to earn $200 million in data licensing and model development fees from the collaborations, the release said.

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ...

Anyone with outdoor plans for the Easter observance could be dodging raindrops or even scattered thunderstorms in the Chicago area. According to the NBC 5 Storm Team, scattered showers and even a ...

Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of ...

CHICAGO (WLS) -- People took to the streets Saturday in Chicago and nationwide to protest President Donald Trump's policies. The protests came as the U.S. Supreme Court issued a new ruling ...